DFPG Investments’s VolitionRx Ltd VNRX Stock Holding History

DFPG Investments’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,257	Closed	-$38.5K	–	642
2023 Q2	$38.5K	Buy	+1,257	New	+$41.4K	﹤0.01%	570

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAMC

Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

DFPG Investments's VNRX Position: Q3 2023 in Review

DFPG Investments sold out of VolitionRx Ltd (VNRX) in Q3 2023, closing a stake of 1,257 shares — an estimated $38.5K sold.

DFPG Investments first reported a position in VNRX in Q2 2023 and held it in 1 quarter. The position peaked at $38.5K in Q2 2023. 28 funds tracked by Wall St. Rank hold VNRX as of Q3 2023.

DFPG Investments reported no remaining VolitionRx Ltd position as of Q3 2023 after selling out during the quarter.
DFPG Investments sold 1,257 VolitionRx Ltd shares in Q3 2023, an estimated $38.5K.
DFPG Investments first reported a position in VolitionRx Ltd in Q2 2023 and held it in 1 quarter.
DFPG Investments's VolitionRx Ltd position peaked at $38.5K in Q2 2023.
28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2023.

Based on DFPG Investments's 13F filing for Q3 2023, filed 13 Nov 2023.